Substantial envelope-specific CD8 T-cell immunity fails to control siv disease

Virology

Volumn 384, Issue 1, 2009, Pages 21-27

  Peut, Viv ^a   Kent, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CTL; Env; Escape; HIV; Macaques; SIV

Indexed keywords

ASPARTYLVALYLPHENYLALANYLGLYCYLASPARAGINYLTRYPTOPHYLPHENYLALANYL ASPARTYLLEUCINE; EMTRICITABINE; EPITOPE; GAG PROTEIN; GAMMA INTERFERON; GILEAD; HISTIDYLTYROSYLTRYPTOPHYLASPARTYLTHREONYLISOLEUCYLARGINYLPHENYLALANINE; METHIONYLASPARAGINYLTRYPTOPHYLPHENYLALANYLLEUCYLASPARAGINYL TRYPTOPHYLVALYLGLUTAMYLASPARTIC ACID; SERYLARGINYLASPARAGINYLLYSYLARGINYLGLYCYLVALYLPHENYLALANYLVALYLLEUCINE; SERYLARGINYLVALYLTYROSYLGLUTAMINYLISOLEUCYLLEUCYLGLUTAMINYLPROLINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TENOFOVIR; THREONYLMETHIONYLSERYLALANYLGLUTAMYLVALYLALANYLGLUTAMYLLEUCYLTYROSINE; UNCLASSIFIED DRUG; VALYLLEUCYLPROLYLVALYLTHREONYLISOLEUCYLMETHIONYLSERYLGLYCYLLEUCYLVALINE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EPITOPE MAPPING; INFECTION CONTROL; INTERFERON PRODUCTION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; TREATMENT RESPONSE; VACCINATION; VIRUS INFECTION; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; GENE PRODUCTS, GAG; MACACA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT FAILURE; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; MACACA; MACACA NEMESTRINA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 58549114847     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.11.030     Document Type: Article

References (28)

1. Allen T.M., Altfeld M., Geer S.C., Kalife E.T., Moore C., O'Sullivan K.M., Desouza I., Feeney M.E., Eldridge R.L., Maier E.L., Kaufmann D.E., Lahaie M.P., Reyor L., Tanzi G., Johnston M.N., Brander C., Draenert R., Rockstroh J.K., Jessen H., Rosenberg E.S., Mallal S.A., and Walker B.D. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79 21 (2005) 13239-13249
2. Amara R.R., Smith J.M., Staprans S.I., Montefiori D.C., Villinger F., Altman J.D., O'Neil S.P., Kozyr N.L., Xu Y., Wyatt L.S., Earl P.L., Herndon J.G., McNicholl J.M., McClure H.M., Moss B., and Robinson H.L. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J. Virol. 76 12 (2002) 6138-6146
3. Batten C.J., Rose R.D., Wilson K.M., Agy M.B., Chea S., Stratov I., Montefiori D.C., and Kent S.J. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. AIDS Res. Hum. Retroviruses 22 6 (2006) 580-588
4. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., Lederman M.M., Benito J.M., Goepfert P.A., Connors M., Roederer M., and Koup R.A. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells. Blood 107 12 (2006) 4781-4789
5. Catanzaro A.T., Roederer M., Koup R.A., Bailer R.T., Enama M.E., Nason M.C., Martin J.E., Rucker S., Andrews C.A., Gomez P.L., Mascola J.R., Nabel G.J., and Graham B.S. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. Vaccine 25 20 (2007) 4085-4092
6. Dale C.J., De Rose R., Stratov I., Chea S., Montefiori D., Thomson S.A., Ramshaw I.A., Coupar B.E., Boyle D.B., Law M., and Kent S.J. Efficacy of DNA and fowlpoxvirus prime/boost vaccines for simian/human immunodeficiency virus. J. Virol. 78 (2004) 13819-13828
7. De Rose R., Batten C.J., Smith M.Z., Fernandez C.S., Peut V., Thomson S., Ramshaw I.A., Coupar B.E., Boyle D.B., Venturi V., Davenport M.P., and Kent S.J. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. J. Virol. 81 1 (2007) 292-300
8. De Rose R., Fernandez C.S., Smith M.Z., Batten C.J., Alcantara S., Peut V., Rollman E., Loh L., Mason R.D., Wilson C.M., Law M.G., Handley A.J., and Kent S.J. Control of viremia following immunotherapy of SIV-infected macaques with peptide pulsed blood. Plos Pathogens e12 4 12 (2008) e 100055 (an online journal)
9. Fernandez C.S., Stratov I., De Rose R., Walsh K., Dale C.J., Smith M.Z., Agy M.B., Hu S.L., Krebs K., Watkins D.I., O'Connor D.H., Davenport M.P., and Kent S.J. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79 9 (2005) 5721-5731
10. Fernandez C.S., Smith M.Z., Batten C.J., De Rose R., Reece J.C., Rollman E., Venturi V., Davenport M.P., and Kent S.J. Vaccine-induced T-cells control reversion of AIDS virus immune escape mutants. J. Virol. 81 8 (2007) 4137-4144
11. Frahm N., Kiepiela P., Adams S., Linde C.H., Hewitt H.S., Sango K., Feeney M.E., Addo M.M., Lichterfeld M., Lahaie M.P., Pae E., Wurcel A.G., Roach T., St John M.A., Altfeld M., Marincola F.M., Moore C., Mallal S., Carrington M., Heckerman D., Allen T.M., Mullins J.I., Korber B.T., Goulder P.J., Walker B.D., and Brander C. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat. Immunol. 7 2 (2006) 173-178
12. Friedrich T.C., Dodds E.J., Yant L.J., Vojnov L., Rudersdorf R., Cullen C., Evans D.T., Desrosiers R.C., Mothe B.R., Sidney J., Sette A., Kunstman K., Wolinsky S., Piatak M., Lifson J., Hughes A.L., Wilson N., O'Connor D.H., and Watkins D.I. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10 3 (2004) 275-281
13. Friedrich T.C., Valentine L.E., Yant L.J., Rakasz E.G., Piaskowski S.M., Furlott J.R., Weisgrau K.L., Burwitz B., May G.E., Leon E.J., Soma T., Napoe G., Capuano III S.V., Wilson N.A., and Watkins D.I. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J. Virol. 81 (2007) 3465-3476
14. Hel Z., Venzon D., Poudyal M., Tsai W.P., Giuliani L., Woodward R., Chougnet C., Shearer G., Altman J.D., Watkins D., Bischofberger N., Abimiku A., Markham P., Tartaglia J., and Franchini G. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques. Nat. Med. 6 10 (2000) 1140-1146
15. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., and Goulder P. CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13 1 (2007) 46-53
16. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., Altfeld M., Brander C., Dixon C., Ramduth D., Jeena P., Thomas S.A., St John A., Roach T.A., Kupfer B., Luzzi G., Edwards A., Taylor G., Lyall H., Tudor-Williams G., Novelli V., Martinez-Picado J., Kiepiela P., Walker B.D., and Goulder P.J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10 3 (2004) 282-289
17. Lisziewicz J., Trocio J., Xu J., Whitman L., Ryder A., Bakare N., Lewis M.G., Wagner W., Pistorio A., Arya S., and Lori F. Control of viral rebound through therapeutic immunization with DermaVir. Aids 19 1 (2005) 35-43
18. Lori F., Lewis M.G., Xu J., Varga G., Zinn Jr. D.E., Crabbs C., Wagner W., Greenhouse J., Silvera P., Yalley-Ogunro J., Tinelli C., and Lisziewicz J. Control of SIV rebound through structured treatment interruptions during early infection. Science 290 5496 (2000) 1591-1593
19. Masemola A.M., Mashishi T.N., Khoury G., Bredell H., Paximadis M., Mathebula T., Barkhan D., Puren A., Vardas E., Colvin M., Zijenah L., Katzenstein D., Musonda R., Allen S., Kumwenda N., Taha T., Gray G., McIntyre J., Karim S.A., Sheppard H.W., and Gray C.M. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J. Immunol. 173 7 (2004) 4607-4617
20. Pal R., Venzon D., Letvin N.L., Santra S., Montefiori D.C., Miller N.R., Tryniszewska E., Lewis M.G., VanCott T.C., Hirsch V., Woodward R., Gibson A., Grace M., Dobratz E., Markham P.D., Hel Z., Nacsa J., Klein M., Tartaglia J., and Franchini G. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J. Virol. 76 1 (2002) 292-302
21. Peut V., and Kent S.J. Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen. J. Virol. 81 23 (2007) 13125-13134
22. Polacino P.S., Stallard V., Klaniecki J.E., Pennathur S., Montefiori D.C., Langlois A.J., Richardson B.A., Morton W.R., Benveniste R.E., and Hu S.L. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in macaques. J. Virol. 73 10 (1999) 8201-8215
23. Pratt B.F., O'Connor D.H., Lafont B.A., Mankowski J.L., Fernandez C.S., Triastuti R., Brooks A.G., Kent S.J., and Smith M.Z. MHC class I allele frequencies in pigtail macaques of diverse origin. Immunogenetics 58 12 (2006) 995-1001
24. Sacha J.B., Chung C., Rakasz E.G., Spencer S.P., Jonas A.K., Bean A.T., Lee W., Burwitz B.J., Stephany J.J., Loffredo J.T., Allison D.B., Adnan S., Hoji A., Wilson N.A., Friedrich T.C., Lifson J.D., Yang O.O., and Watkins D.I. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178 5 (2007) 2746-2754
25. Shen A., Zink M.C., Mankowski J.L., Chadwick K., Margolick J.B., Carruth L.M., Li M., Clements J.E., and Siliciano R.F. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus - Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. J. Virol. 77 8 (2003) 4938-4949
26. Smith M.Z., Dale C.J., De Rose R., Stratov I., Fernandez C.S., Brooks A.G., Weinfurter J.T., Krebs K., Riek C., Watkins D.I., O'Connor D.H., and Kent S.J. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol. 79 (2005) 684-695
27. Smith M.Z., Fernandez C.S., Chung A., Dale C.J., De Rose R., Lin J., Brooks A.G., Krebs K.C., Watkins D.I., O'Connor D.H., Davenport M.P., and Kent S.J. The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion. J. Med. Primatol. 34 5-6 (2005) 282-293
28. Villinger F., Brice G.T., Mayne A.E., Bostik P., Mori K., June C.H., and Ansari A.A. Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Blood 99 2 (2002) 590-599